These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36453542)

  • 21. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications.
    Maddiboyina B; Ramaiah ; Nakkala RK; Roy H
    Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in lipid-based nanoparticles for cancer therapy.
    Grinberg S; Linder C; Heldman E
    Crit Rev Oncog; 2014; 19(3-4):247-60. PubMed ID: 25271433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer.
    Roostaee M; Derakhshani A; Mirhosseini H; Banaee Mofakham E; Fathi-Karkan S; Mirinejad S; Sargazi S; Barani M
    Nanoscale; 2024 Feb; 16(6):2713-2746. PubMed ID: 38213285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.
    Ma Z; Fan Y; Wu Y; Kebebe D; Zhang B; Lu P; Pi J; Liu Z
    Int J Nanomedicine; 2019; 14():2029-2053. PubMed ID: 30962686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted drug delivery systems for elemene in cancer therapy: The story thus far.
    Tian H; Zhao F; Qi QR; Yue BS; Zhai BT
    Biomed Pharmacother; 2023 Oct; 166():115331. PubMed ID: 37598477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A DNA-Based Nanocarrier for Efficient Gene Delivery and Combined Cancer Therapy.
    Liu J; Song L; Liu S; Jiang Q; Liu Q; Li N; Wang ZG; Ding B
    Nano Lett; 2018 Jun; 18(6):3328-3334. PubMed ID: 29708760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency.
    Li W; Fu J; Ding Y; Liu D; Jia N; Chen D; Hu H
    Acta Biomater; 2019 Sep; 96():456-467. PubMed ID: 31260821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells.
    Chen Y; Chen H; Shi J
    Mol Pharm; 2014 Aug; 11(8):2495-510. PubMed ID: 24224544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols.
    Tie S; Tan M
    J Agric Food Chem; 2022 Feb; 70(4):903-915. PubMed ID: 35072455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.
    Ning Q; Liu YF; Ye PJ; Gao P; Li ZP; Tang SY; He DX; Tang SS; Wei H; Yu CY
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10578-10588. PubMed ID: 30802029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination Cancer Therapy Using Multifunctional Liposomes.
    Jain A; Tiwari A; Verma A; Saraf S; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):105-134. PubMed ID: 32865902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy.
    Mohanty A; Uthaman S; Park IK
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32977707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.